SV Health Investors News on Feedspot

SV Health Investors News

62 FOLLOWERS

The latest SV company and portfolio news. SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Their goal is to transform healthcare one investment at a time.

Miach Orthopaedics Raises $20 Million in Series B Extension

SV Health Investors News

5d ago

Visit website

Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants

SV Health Investors News

5d ago

Visit website

Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024

SV Health Investors News

5d ago

Visit website

Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole

SV Health Investors News

5d ago

Visit website

Dementia Discovery Fund Look Ahead: 2024 is shaping up to be another big year in the fight against dementia

SV Health Investors News

3w ago

Visit website

SV Biotech launches its inaugural ESG and Impact Report

SV Health Investors News

3w ago

Visit website

Cumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia

SV Health Investors News

3w ago

Visit website

On International Women's Day SV Venture Partner Ruth McKernan reflects on some achievements of SV biotech portfolio companies

SV Health Investors News

1M ago

Visit website

Ribometrix to Present New Preclinical Data From RNA-Modulating Small Molecule Programs Targeting eIF4E and c-MYC at the 2024 AACR Annual Meeting

SV Health Investors News

1M ago

Visit website

Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference

SV Health Investors News

1M ago

Visit website

Follow SV Health Investors News on FeedSpot